Eruptive syringomas: unresponsiveness to oral isotretinoin.
Department of Dermatology, State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.
Marina
M
Papageorgiou
Department of Dermatology, State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.
Grigorios
G
Theodosiou
Department of Dermatology, State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.
Ioanna
I
Mandekou-Lefaki
D000284:Administration, Oral; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D013544:Sweat Gland Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018252:Syringoma / Q000188:drug therapy* / Q000473:pathology; D017211:Treatment Failure; D055815:Young Adult
D003879:Dermatologic Agents; D015474:Isotretinoin